期刊文献+

多重耐药鲍曼不动杆菌表型及耐药基因型的研究 被引量:18

Study on phenotype and genotype of multiresistant Acinetobacter baumannii
下载PDF
导出
摘要 目的对我院临床分离的31株多重耐药鲍曼不动杆菌表型和耐药基因进行分析。方法用纸片扩散法检测鲍曼不动杆菌的药敏结果,用三维试验检测超广谱β-内酰胺酶(ESBL)、头孢菌素酶(AmpC酶),用协同法检测金属β-内酰胺酶(MBL),用聚合酶链反应(PCR)检测耐药基因。结果31株多重耐药鲍曼不动杆菌中,90%对亚胺培南敏感;22%对头孢哌酮-舒巴坦耐药,74%中介;其他抗菌药物的敏感率均在6%以下。2株菌(6%)单产ESBL;93%菌株高产AmpC酶,其中19%菌株同时产ESBL。所有菌株b laTEM、aacA4和gyrA基因均为阳性;96%菌株ampC基因为阳性;2株菌同时携带b laPER和b laOXA-23型基因,另有1株菌b laOXA-23基因阳性。结论同时携带b laTEM、ampC、aacA4和gyrA突变以及b laPER、b laOXA-23等多种耐药基因是鲍曼不动杆菌多重耐药的主要原因。 Objective To analyse the resistant genotype and phenotype of 31 strains of multiresistant Acinetobacter baumannii in clinical isolation from our hospital. Methods Antibiotic susceptibility tests were performed by K-B methods, three dimensional extract tests were performed to detect extended spectrum β-lactamase (ESBL)-producing strains and cephalosporinase (AmpC)-producing strains, metallo-β-lactamases (MBL)-producing strains were detected by synergetic tests, and the resistant genes were amplified by polymerase chain reaction (PCR). Results In 31 strains ofmuhiresistant Acinetobacter baumannii, 90% were susceptible to imipenem; 22% were resistant to cefoperazone/sulbactam and 74% were intermediate; other antibiotic susceptibility was not over 6% ; 2 strains produced ESBL; 93% strains produced AmpC and 19% strains produced ESBL at the same time. blaTEM, aacA4 and gyrA genes were positive in all strains; ampC genes in 96% strains were positive; blapER and blaoxs_23 genes were both positive in 2 strains, another strain carried blaOXA-23 genes. Conclusions Carring several resistant genes including blaTEM , and ampC, aacA4, mutation of gyrA and blaFER et al mav be main reason that causes Acinetobacter baumannii multidrug resistant.
出处 《检验医学》 CAS 北大核心 2006年第4期398-401,共4页 Laboratory Medicine
基金 铜陵市科技局科研课题资助项目(05A1226) 安徽省卫生厅自然科研课题资助项目(2002A012)
关键词 鲍曼不动杆菌 多重耐药 表型 基因型 Acinetobacter baumannii Multiresistance Phenotype Genotype
  • 相关文献

参考文献10

  • 1Bou G,Cervero G,Dominguez MA,et al.Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:high-level carbapenem resistance in A.baumannii is not due solely to the oresence of β-lactamases[J].J Clin Microbiol,2000,38:3299-3305.
  • 2方平,潘晓龙,周东升,吴同生,吴祥林.产超广谱β内酰胺酶和高产AmpC酶革兰阴性杆菌耐药性检测[J].中国抗感染化疗杂志,2005,5(5):270-274. 被引量:13
  • 3Lee K,Lim YS,Yong D,et al.Evaluation of the hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-roducing isolates of Pseudomonas spp and Acinetobacter spp[J].J Clin Microbiol,2003,41:4623-4629.
  • 4Afzal-Shah M,Woodford N,Livermore DM.Characterization of OXA-25,OXA-26,and OXA-27,molecular class D β-lactamase associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii[J].Antimicrob Agents Chemother,2001,45:583-588.
  • 5黄支密,陈榆,毛培华,吴晶,仵蕾.鲍曼不动杆菌耐药性及β内酰胺酶基因型研究[J].中华检验医学杂志,2003,26(11):683-685. 被引量:86
  • 6Beceiro A,Dominguez L,Ribera A,et al.Molecular characterization of the gene encoding a new AmpC βlactamase in a clinical strain of Acinetobacter genomic species 3[J].Antimicrob Agents Chemother,2004,48:1374-1378.
  • 7Hujer KM,Hamza NS,Hujer AM,et al.Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase,ADC-7 β-1actamase:defining a unique family of class C enzymes[J].Antimicrob Agents Chemother,2005,49:2941-2948.
  • 8Vila J,Ruiz J,Navia M,et al.Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain[J].J Clin Microbiol,1999,37:758-761.
  • 9Gallego L,Towner KJ.Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain[J].J Med Microbiol,2001,50:71-77.
  • 10Vila J,Ruiz J,Gon P,et al.Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii[J].Antimicrob Agents Chemother,1995,39:1201-1203.

二级参考文献13

共引文献97

同被引文献190

引证文献18

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部